Трансуретральная резекция предстательной железы по поводу инфравезикальной обструкции у больных с сахарным диабетом 2 типа

Трансуретральная резекция предстательной железы по поводу инфравезикальной обструкции у больных с сахарным диабетом 2 типа

Автор: Волков С.Н., Михеев Р.К., Григорян О.Р., Терещенко В.И., Степанченко В.С., Андреева Е.Н.

Журнал: Экспериментальная и клиническая урология @ecuro

Рубрика: Эндоурология

Статья в выпуске: 1 т.17, 2024 года.

Бесплатный доступ

Введение. Обструкция вследствие доброкачественной гиперплазии предстательной железы (ДГПЖ) является распространенным заболеванием у мужчин с сахарным диабетом 2 типа (СД 2).

Доброкачественная гиперплазия предстательной железы, сахарный диабет, сравнительный анализ, трансуретральная резекция предстательной железы

Короткий адрес: https://sciup.org/142241821

IDR: 142241821   |   DOI: 10.29188/2222-8543-2024-17-1-94-99

Список литературы Трансуретральная резекция предстательной железы по поводу инфравезикальной обструкции у больных с сахарным диабетом 2 типа

  • Verhamme KM, Dieleman JP, Bleumink GS, van der Lei J, Sturkenboom MC, Artibani W, et al. Triumph Pan European Expert Panel. Incidence and prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care – the Triumph project. Eur Urol 2002;42(4):323–8. https://doi.org/10.1016/s0302-2838(02)00354-8.
  • Litman HJ, McKinlay JB. The future magnitude of urologic symptoms in the USA: projections using the Boston Area Community Health survey. BJU Int 2007;100(4):820–5. https://doi.ort/10.1111/j.1464-410X.2007.07018.x.
  • Saigal CS, Joyce G. Economic costs of benign prostatic hyperplasia in the private sector. J Urol 2005;173(4):1309–13. https://doi.org/10.1111/j.1464-410X.2007.07018.x.
  • Irwin DE, Kopp ZS, Agatep B, Milsom I, Abrams P. Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction. BJU Int 2011;108(7):1132–8. https://doi.org/10.1111/j.1464-410X.2010.09993.x.
  • NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet 2016;387(10027):1513–30. https://doi.org/10.1016/S0140-6736(16)00618-8.
  • Sasaki K, Yoshimura N, Chancellor MB. Implications of diabetes mellitus in urology. Urol Clin North Am 2003;30(1):1–12. https://doi.org/10.1016/s0094-0143(02)00116-7.
  • Yuan Z, Tang Z, He C, Tang W. Diabetic cystopathy: a review. J Diabetes 2015;7(4):442–7. https://doi.org/10.1111/1753-0407.12272.
  • Sarma AV, Burke JP, Jacobson DJ, McGree ME, St Sauver J, Girman CJ, et al. Associations between diabetes and clinical markers of benign prostatic hyperplasia among community-dwelling Black and White men. Diabetes Care 2008;31(3):476–82. https://doi.org/10.1111/1753-0407.12272.
  • Liu RT, Chung MS, Lee WC, Chang SW, Huang ST, Yang KD, et al. Prevalence of overactive bladder and associated risk factors in 1359 patients with type 2 diabetes. Urology 2011;78(5):1040–5. https://doi.org/10.1016/j.urology.2011.05.017.
  • Michel MC, Mehlburger L, Schumacher H, Bressel HU, Goepel M. Effect of diabetes on lower urinary tract symptoms in patients with benign prostatic hyperplasia. J Urol 2000;163(6):1725–9.
  • Hsing AW, Ioannidis JP. Nationwide population science: lessons from the Taiwan National Health Insurance Research Database. JAMA Intern Med 2015;175(9):1527–9. https://doi.org/10.1001/jamainternmed.2015.3540.
  • Hsiao F, Yang C, Huang Y, Huang WF. Using Taiwan’s national health insurance research databases for pharmacoepidemiology research. J Food Drug Anal 2007;15(2):99.
  • Lin YH, Hou CP, Chen TH, Juang HH, Chang PL, Yang PS, et al. Is diabetes mellitus associated with clinical outcomes in aging males treated with transurethral resection of prostate for bladder outlet obstruction: implications from Taiwan Nationwide Population-Based Cohort Study. Clin Interv Aging 2017;12:535-41. https://doi.org/10.2147/CIA.S126207.
  • Jangir RN, Jain GC. Diabetes mellitus induced impairment of male reproductive functions: a review. Curr Diabetes Rev 2014;10(3):147–57. https://doi.org/10.2174/1573399810666140606111745.
  • Sampson N, Zenzmaier C, Heitz M, Hermann M, Plas E, Schäfer G, et al. Stromal insulin-like growth factor binding protein 3 (IGFBP3) is elevated in the diseased human prostate and promotes ex vivo fibroblast-tomyofibroblast differentiation. Endocrinology 2013;154(8):2586–99. https://doi.org/10.1210/en.2012-2259.
  • Qian Q, He W, Liu D, Yin J, Ye L, Chen P, et al. M2a macrophage can rescue proliferation and gene expression of benign prostate hyperplasia epithelial and stroma cells from insulin-like growth factor 1 knockdown. Prostate 2021;81(9):530-42. https://doi.org/10.1002/pros.24131.
  • Rassweiler J, Teber D, Kuntz R, Hofmann R. Complications of transurethral resection of the prostate (TURP) – incidence, management, and prevention. Eur Urol 2006;50(5):969–80. https://doi.org/10.1016/j.eururo.2005.12.042.
  • Yamaguchi C, Sakakibara R, Uchiyama T, Yamamoto T, Ito T, Liu Z, et al. Overactive bladder in diabetes: a peripheral or central mechanism? Neurourol Urodyn 2007;26(6):807–13. https://doi.org/10.1002/nau.20404.
  • Moul S, McVary KT. Lower urinary tract symptoms, obesity and the metabolic syndrome. Curr Opin Urol 2010;20(1):7–12. https://doi.org/10.1097/ MOU.0b013e3283336f3f.
  • Daneshgari F, Liu G, Hanna-Mitchell AT. Path of translational discovery of urological complications of obesity and diabetes. Am J Physiol RenalPhysiol 2017;312(5):F887-F896. https://doi.org/10.1152/ajprenal.00489.2016.
  • Baptista FI, Pinheiro H, Gomes CA, Ambrósio AF. Impairment of axonal transport in diabetes: focus on the putative mechanisms underlying peripheral and central neuropathies. Mol Neurobiol 2019;56(3):2202-10. https://doi.org/10.1007/s12035-018-1227-1.
  • Zilliox LA. Diabetes and peripheral nerve disease. Clin Geriatr Med 2021;37(2):253-67. https://doi.org/10.1016/j.cger.2020.12.001.
  • Røikjer J, Mørch CD, Ejskjaer N. Diabetic peripheral neuropathy: diagnosis and treatment. Curr Drug Saf 2021;16(1):2-16. https://doi.org/10.2174/1574886315666200731173113
  • Issar T, Tummanapalli SS, Borire AA, Kwai NCG, Poynten AM, Arnold R, et al. Impact of the metabolic syndrome on peripheral nerve structure and function in type 2 diabetes. Eur J Neurol 2021;28(6):2074-82. https://doi.org/10.1111/ene.14805.
  • Ozturk Y, Altan VM, Yildizoglu-Ari N. Effects of experimental diabetes and insulin on smooth muscle functions. Pharmacol Rev 1996;48(1):69–112.
  • Thomas AW, Cannon A, Bartlett E, Ellis-Jones J, Abrams P. The natural history of lower urinary tract dysfunction in men: minimum 10-year urodynamic follow-up of untreated bladder outlet obstruction. BJU Int 2005;96(9):1301–6. https://doi.org/10.1111/j.1464-410X.2005.05815.x.
  • Zhu Y, Zhao YR, Zhong P, Qiao BM, Yang ZQ, Niu YJ. Detrusor underactivity influences the efficacy of TURP in patients with BPO. Int Urol Nephrol 2021;53(5):835-41. https://doi.org/10.1007/s11255-020-02750-1.
  • Xu D, Zhao M, Huang L, Wang K. Overactive bladder symptom severity, bother, help-seeking behavior, and quality of life in patients with type 2 diabetes: a path analysis. Health Qual Life Outcomes 2018;16(1):1. https://doi.org/10.1186/s12955-017-0829-z.
  • Wang CC, Liao CH, Liu HT, Lin JM, Kuo HC. Association of urinary nerve growth factor levels with erectile function in young men with type 2 diabetes mellitus. Int J Impot Res 2017;29(3):101-4. https://doi.org/10.1038/ijir.2017.2.
  • Lee WC, Lin YH, Hou CP, Chang PL, Chen CL, Juang HH, et al. Prostatectomy using different lasers for the treatment of benign prostate hyperplasia in aging males. Clin Interv Aging 2013;8:1483–8. https://doi.org/10.2147/CIA.S52697.
Еще
Статья научная
QR-код для установки приложения SciUp Наведите камеру и скачайте бесплатное приложение SciUp